Indeed, there is a high degree of NET–IL‐1β interplay during both venous and arterial thrombosis and severe asthma (Lachowicz‐Scroggins et al., 2019; Liberale et al., 2019; Yadav et al., 2019), and it has been hypothesised that there may be therapeutic potential in targeting the IL‐1β/NET feedback loop (Yaqinuddin & Kashir, 2020). The gene discussed is IL1B; the disease is deep vein thrombosis.